Institutional investors hold a majority ownership of THOR through the 91.02% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended June 2014, these large investors purchased a net $113.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FOX ASSET MANAGEMENT LLC Bought 2.4 Thousand shares of Thoratec Corp
CLOUD CAPITAL LLC Sold 252.00 shares of Thoratec Corp
ARDEN ASSET MANAGEMENT LLC Sold 412.00 shares of Thoratec Corp